Artelo Biosciences Inc ARTL:NASDAQ

Last Price$0.33NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/20/22

Today's Change+0.0008(0.24%)
Bid (Size)$0.32 (9)
Ask (Size)$0.33 (1)
Day Low / High$0.33 - 0.36
Volume228.7 K

Artelo Biosciences' Lead Cannabinoid No Longer Schedule 1 Controlled Substance in UK; Shares Rise Pre-Bell

9:30AM ET 1/11/2022 MT Newswires
Artelo Biosciences (ARTL) reported that the UK government no longer considers the company's lead clinical cannabinoid ART27.13 a Schedule 1 controlled substance, lifting limitations on its production, possession and supply.

"Artelo will be able to treat ART27.13 as a normal, non-scheduled investigational medicinal product, which is expected to streamline onboarding of additional clinical sites in the UK, accelerate enrollment of patients, and enhance the commercial potential of ART27.13," said Chief Scientific Officer Andrew Yates.

The pharmaceutical company said it is currently enrolling patients in the UK in a phase 1/2 study to evaluate ART27.13 to treat anorexia in people with cancer. Shares of Artelo Biosciences are up more than 4% in premarket trading.

Price: 0.48, Change: +0.02, Percent Change: +4.37